Skip to main content Skip to footer
Follow us on:
  • Podcast
    • Apple Podcast
    • Spotify
    • Amazon Music and Audible
ATRI
  • About
    • Mission and Vision
    • ATRI Leadership
    • Timeline
    • Careers
  • Research
    • Clinical Trials
      • Sections
      • Studies
      • Site Locations
      • Participate
    • Basic Science
  • Education
    • Alzheimer’s Research Day San Diego
    • Student Summer Research Program
  • People
    • Our People
    • Leadership
    • Faculty & Team Leads
    • Teams
  • Resources
    • News & Events
    • Events Calendar
    • Resource Library
  • Donate Now

Alzheimer’s Studies and Trials

Reset Filter
Actively Enrolling
50-85, Clinical Trial, Memory Impairement

Synaptic Therapy Alzheimer’s Research Trial

This study is investigating whether CT1812, a novel and promising therapeutic candidate can halt or slow the process of Alzheimer’s disease. The START Study is a nationwide clinical trial and…
Learn More
Actively Enrolling
40+, Clinical Trial, Memory Impairement

Life’s End Benefits of Cannabidiol and Tetrahydrocannabinol (LiBBY)

Approximately fifty percent of people diagnosed with Alzheimer’s disease or other types of dementia will receive hospice care at the end of their life. Of these, over seventy percent will…
Learn More
Active – Fully Enrolled
50-90, Memory Impairement, Normal Memory, Observational - In Person

Alzheimer’s Disease Neuroimaging Initiative (ADNI)

The Alzheimer’s Disease Neuroimaging Initiative (ADNI), a landmark study that began in 2004, is a public-private research partnership tasked with identifying biomarkers to detect Alzheimer’s disease (AD). The study has…
Learn More
9860 Mesa Rim Road,
San Diego, CA 92121

ATRIinfo@usc.edu

Phone: (858) 964-4644
Fax: (858) 622-1904
  • Contact
  • Take Action
  • Donate Now
  • Careers
  • Education Programs
  • Digital Accessibility

Sign up for our Newsletter

Stay up to date with the latest news in Alzheimer’s therapeutics.